Setrosil 0.25mg Injection
Marketer
Serum Institute Of India Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Setrosil 0.25mg Injection
Cetrorelix 0.25mg Injection is a GnRH antagonist indicated for female infertility treatment. It suppresses egg release, preventing premature ovulation. Administration is via subcutaneous injection under medical supervision; self-injection is prohibited. Your healthcare provider will instruct you on proper home injection technique. Dosage and frequency vary depending on the therapeutic indication; your physician will determine the optimal regimen to manage your condition. Continue treatment as prescribed. Common side effects include injection site reactions (erythema, pruritus, irritation), nausea, and emesis. Rotate injection sites (abdomen) daily to minimize irritation. Report dizziness, syncope, abdominal pain, or persistent vomiting immediately. Prior to treatment, disclose any history of hepatic or renal impairment, or breastfeeding status. Inform your doctor of all concomitant medications, as interactions may affect efficacy or alter drug metabolism.
Primary Ingredients of Setrosil 0.25mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Setrosil 0.25mg Injection
Inability to conceive in women
Major Benefits of Setrosil 0.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Setrosil 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Setrosil 0.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Setrosil 0.25mg Injection works:
For women receiving infertility treatment, early egg release may occur before the eggs are mature enough for fertilization. Setrosil 0.25mg Injection inhibits a natural hormone, thereby preventing premature ovarian follicle rupture.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Setrosil 0.25mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Setrosil 0.25mg Injection to pregnant individuals poses a considerable risk. Pregnant women should consult their physician before use, as research in animal and human studies has revealed substantial adverse effects on fetal development.
Breast feedingUNSAFE
Administering Setrosil 0.25mg Injection while breastfeeding is contraindicated due to potential infant toxicity indicated by available evidence.
DrivingSAFE
Administering Setrosil 0.25mg Injection typically has no impact on driving capabilities.
KidneyCAUTION
Administering Setrosil 0.25mg Injection to individuals with impaired kidney function requires careful consideration and potential dose modification. Physician consultation is essential. Setrosil 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Setrosil 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Setrosil 0.25mg Injection :
Should you forget a dose of Setrosil 0.25mg Injection, seek your physician's advice.
Facts to Know About Setrosil 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Behavioral Class | GnRH receptor antagonists |
3,018 People bought this recently